Bladder cancer
|
∆ DANCR: ↓ tumor volume, tumor growth and metastasis
|
[8]
|
∆ DANCR: ↓ tumor weight, and tumor growth
|
[9]
|
Breast cancer
|
∆ DANCR: ↓ tumor growth
|
[27]
|
∆ DANCR: ↓ tumor growth
|
[29]
|
∆ DANCR: ↓ tumor growth
|
[35]
|
∆ DANCR: ↓ tumor weight, tumor volume
|
[36]
|
∆ DANCR: ↓ tumor growth
|
[37]
|
RGD-PEG-ECO/siDANCR nanoparticles: ↓ proliferation
|
[38]
|
Cervical cancer
|
∆ DANCR: ↓ tumor growth
|
[40]
|
∆ DANCR: ↓ tumor weight, tumor volume, and tumor growth
|
[41]
|
↑ miR-665 (a target of DANCR): ↓ tumor weight and tumor growth
|
[42]
|
Cholangiocarcinoma
|
∆ DANCR: ↓ tumor growth
|
[43]
|
∆ DANCR: ↓ tumor weight and tumor growth
|
[44]
|
Colon cancer
|
∆ DANCR: ↓ glycolysis rate and ↑ cisplatin sensitivity
|
[21]
|
∆ DANCR: ↓ tumor formation and metastasis
|
[22]
|
∆ DANCR: ↓ tumor volume, and tumor growth
|
[45]
|
Colorectal cancer
|
↑↑ DANCR: ↑ tumor volume and tumor growth
|
[49]
|
Gastric cancer
|
∆ DANCR: ↓ tumor growth
|
[31]
|
∆ DANCR: ↓ tumor weight, tumor volume, tumor size and proliferation
|
[32]
|
↑↑ DANCR: ↑ cell growth and tumorigenicity
|
[54]
|
Glioma
|
∆ DANCR: ↓ tumor weight, tumor volume, and tumor growth
|
[55]
|
∆ DANCR: ↑ apoptosis-inducing roles of cisplatin in vivo
|
[58]
|
Hepatocellular carcinoma
|
↑↑ DANCR: ↑ sorafenib resistance
|
[18]
|
∆ DANCR: ↓ cell vitality, tumor shrinkage
|
[19]
|
∆ DANCR: ↓ tumor growth and lung metastasis
|
[20]
|
∆ DANCR: ↓ tumor growth and lung metastasis
|
[62]
|
Lung cancer
|
∆ DANCR: ↓ tumor growth
|
[10]
|
∆ DANCR: ↓ tumor growth
|
[12]
|
∆ DANCR: ↓ tumor weight, tumor volume and tumor growth
|
[65]
|
∆ DANCR: ↓ tumor growth
|
[66]
|
∆ DANCR: ↓ tumor volume
|
[67]
|
Nasopharyngeal carcinoma
|
∆ DANCR: ↓ tumor size and tumor growth
|
[71]
|
∆ DANCR: ↓ tumor volume and tumor weight
|
[72]
|
∆ DANCR: ↓ invasion and metastasis
|
[73]
|
Oral squamous cell carcinoma
|
∆ DANCR: ↓ tumor weight, tumor volume, and tumor growth
|
[75]
|
Osteosarcoma
|
↑↑ DANCR: ↑ tumor growth and metastasis
|
[3]
|
∆ DANCR: ↓ tumor size and tumor volumes
|
[2]
|
∆ DANCR: ↓ tumor growth and autophagy
|
[5]
|
∆ METTL3: ↓ tumor volumes (DANCR could be a target of METTL3)
|
[6]
|
Ovarian cancer
|
∆ DANCR: ↓ tumor weight, tumor volume, and tumor growth
|
[78]
|
Pancreatic cancer
|
DANCR was up-regulated as pancreatic cancer progressed
|
[89]
|
∆ DANCR: ↓ tumor growth
|
[25]
|
Prostate cancer
|
∆ DANCR: ↓ tumor weight, tumor volume, and tumor growth
|
[84]
|
∆ DANCR: ↓ metastasis
|
[85]
|
Tongue squamous cell carcinoma
|
∆ DANCR: ↓ tumor growth and tumor formation
|
[88]
|